Inovio Pharmaceuticals, Inc.
Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same
Last updated:
Abstract:
Provided herein are consensus amino acid sequences of prostate antigens that are capable of breaking tolerance in a targeted species, including PSA, PSMA, STEAP and PSCA antigens. Also provided are nucleic acid sequences that encode one or more consensus amino acid sequences of prostate antigens PSA, PSMA, STEAP and PSCA, as well as genetic constructs/vectors and vaccines expressing the sequences. Also provided herein are methods for generating an autoimmune response against prostate cancer cells by administering one or more of the vaccines, proteins, and/or nucleic acid sequences that are provided.
Status:
Grant
Type:
Utility
Filling date:
31 Jan 2018
Issue date:
29 Jun 2021